Journal of Medicinal Plants Studies 2021; 9(2): 40-47
ISSN (E): 2320-3862
ISSN (P): 2394-0530
NAAS Rating: 3.53
www.plantsjournal.com
JMPS 2021; 9(2): 40-47
© 2021 JMPS
Received: 22-12-2020
Accepted: 28-01-2021
Florence Chimezie Nwinyi
Department of Pharmacology
and Toxicology, Faculty of
Veterinary Medicine, University
of Abuja, Nigeria
Paul Abdu
Department of Veterinary
Medicine, Ahmadu Bello
University, Zaria, Nigeria
Shehu Naallah Alhaji Saidu
Department of Veterinary
Medicine, Ahmadu Bello
University, Zaria, Nigeria
Joseph Omamegbe
Department of Surgery, Faculty
of Veterinary Medicine,
University of Abuja, Nigeria
Adamu Mohammed
Department of Pharmacology
and Toxicology, Faculty of
Veterinary Medicine, University
of Abuja, Nigeria
Evaluation of aqueous-methanol stem bark
extract of Stereospermum kunthianum Cham.
(Family: Bignoniaceae) for Anti-inflammatory
and antinociceptive effects
Florence Chimezie Nwinyi, Paul Abdu, Shehu Naallah Alhaji Saidu,
Joseph Omamegbe and Adamu Mohammed
Abstract
Stereospermum kunthianum Cham (Family; Bignoniaceae) is a plant that has its different parts used in
traditional medicine for the treatment of different ailments. Its stem bark extract is used for treatment of
wounds, ulcers, gastritis, bronchitis and other pain and inflammatory related health conditions. This study
was prompted by the need to authenticate some of these ethnomedicinal claims. The stem bark of S.
kunthianum was successively macerated in 80 % v/v methanol and the extract was used to evaluate its
usefulness in pain and inflammatory conditions. The aqueous-methanol extract of S. kunthianum was
analysed for phytochemical constituents. Its acute toxicity profile was determined in rats and mice. Antiinflammatory activity of the extract was evaluated using fresh egg albumin-induced paw oedema model
and formalin-induced paw oedema model in rats. The extract was also tested for anti-nociceptive effect
using acetic acid-induced writhing test in mice and formalin-induced pain test in rats. The results
revealed that saponins, terpenes, tannins and steroids were present in the extract. The estimated oral and
intraperitoneal median lethal dose (LD50) of the extract in rats was ≥ 5,000 mg/kg. The intraperitoneal
LD50 of the extract in mice was also ≥ 5,000 mg/kg. The extract (100, 200 and 400 mg/kg i.p) reduced
egg albumin-induced paw oedema in rat over a period of 120 min (2 h). The reduction was significant (p
< 0.05) up to 60 min. and the percent inflammatory inhibition for the extract was comparable to that of
acetyl salicylic acid (ASA, 100 mg/kg i.p). Formalin-induced oedema test also revealed that S.
kunthianum reduced paw oedema in rats up to Day 6 and the reduction effect was higher than that of
ASA (100 mg/kg p.o). Acetic acid-induced writhing test for anti-nociception showed that S. kunthianum
(100 – 400 mg/kg i.p) significantly (p < 0.05) reduced the number of acetic acid-induced writhes in mice
over 120 min and the reduction was dose-dependent. The extract doses of 200 and 400 mg/kg had higher
percent inhibition of nociception than the tested dose of acetyl salicylic acid (100 mg/kg p.o). Antinociceptive study also revealed that S. Kunthianum (100, 200 and 400 mg/kg i.p) caused a significant (p
< 0.05) reduction of formalin-induced pain at the late phase (15 – 60 min). The reduction was not dosedependent and was comparable to that of ASA (100 mg/kg i.p). The extract (100, 200 and 400 mg/kg i.p)
produced non-significant pain inhibition in the early phase (0 – 10 min). In conclusion, the study showed
the justification for the ethno-medicinal use of S. kunthianum stem bark extract for the treatment of
inflammatory and pain-related health conditions. The findings are also suggestive of peripheral
mechanism of action. S. kunthianum stem bark extract therefore has the potential to be developed as antiinflammatory and analgesic agent.
Keywords: Stereospermum kunthianum, anti-inflammation, anti-nociception, phytoconstituents, acute
Corresponding Author:
Florence Chimezie Nwinyi
Department of Pharmacology
and Toxicology, Faculty of
Veterinary Medicine, University
of Abuja, Nigeria
Introduction
Inflammatory response involves a spectrum of cellular and systemic events that occur in which
the host attempts to restore and maintain homeostasis following any one of a variety of tissue
injuries; either by mechanical or chemical agents or by self-destruction/auto-immune processes
[1, 2]
. This therefore shows that, although there is a tendency in clinical medicine to consider the
inflammatory response as harmful reaction to the body, it is essentially a ‘protective’ and
‘restorative’ response in which the body attempts either to return to the pre-injury condition or
to repair itself after inflicted injury [3].
However, if the inflammatory response is ‘aberrant’, a serious consequence may occur. For
instance, an outpouring of too much fluid from the vasculature into an area such as the brain
may lead to a serious rise in intracranial pressure.
~ 40 ~
Journal of Medicinal Plants Studies
http://www.plantsjournal.com
development of anti-inflammatory and/or analgesic agent(s).
It is a deciduous shrub or small tree widely spread across
Africa with some species distribution in Asia. S. kunthianum
is found in wooded savanna, bush, rocky outcrops and
margins of evergreen forests. The species is well spread all
over the Sahel region and is often found near streams [19]. It
grows 3-15 m high, with a stem diameter of 25 cm. It has thin,
grey-black bark, smooth or flaking in patches resembling the
European plane tree; the trunk is rarely straight, mostly
forked, with twisted branches. The leaves are impairpinnately compound, 25 cm long, alternate with 2-6 leaflets.
The flowers are precocious (early development), fragrant with
mauve to off-white, more usually pinkish with red streaks.
The fruits are slender with flat capsules or paired pods [20].
S. kunthianum is commonly called ‘Pink Jacaranda’ in
English. In Nigeria, it is known as dan Sarkin-itatuwa,
sansami (Hausa), weknavunihi (Gwari), buldumhi golombi
(Fula-fulfude), golombi (Kanuri) umana tumba (TIV), ajade,
ayada, afe (Yoruba).
The accumulation of fluid due to inflammation in the pleural
and pericardial cavities may seriously compromise organ
function [4, 5]. Also, the arrival of excessive numbers of
neutrophils and the subsequent discharge of their enzymatic
contents may result in serious structural damage [6].
It has been shown that many diseases confronting the
clinician are due to an uncontrolled inflammatory response.
The joint damage in rheumatoid arthritis, the functional and
structural damage in glomerulonephritis, and the
demyelinating diseases of the central nervous system are
examples of excessive or uncontrolled inflammatory
response. The treatment usually involves anti-inflammatory
therapy since information about the causative agents of these
entities is not well known [7, 8].
Pain is on the other hand defined as an unpleasant sensory and
emotional experience associated with actual or potential tissue
damage [9] and it is categorized into: ‘nociceptive pain’ and
‘neuropathic pain’. Nociceptive pain is the normal
physiological response to a painful stimulus and serves as a
biologic function to warn of injury. In the nociceptive pain
pathway, there are nociceptors which are free primary nerve
endings found in cutaneous muscle and visceral tissues [10].
The nociceptors are normally silent when not stimulated but
can be stimulated in two ways: actual injury to the tissue or
changes in the tissues surrounding the area of injury. Tissue
damage caused by noxious (harmful, injurious) stimulation
precipitates cellular changes. The pH changes, enzymes and
mediators are activated and released and there may be ionic
changes
influencing
membrane
permeability.
The
inflammatory cascade is stimulated; histamine and serotonin
are released increasing vasodilation and inflammation. Some
or all of these stimulate the free nociceptor nerve endings [10].
After the stimulation of the nociceptors, the cellular changes
in the nerve endings are converted to an electrical impulse in
the primary afferent nerve. This impulse continues travelling
and ascending to the dorsal or ventral roots of the spinal cord
[11]
.
Materials and Methods
Plant Collection and Identification
Fresh plant materials of Stereospermum kunthianum stem
bark were collected in the month of December from Suleja,
Niger State, which is situated at 10o00’N 6o00’E, Nigeria. The
plant was identified by a Plant Taxonomist with the
Herbarium Unit, Department of Medicinal Plants Research
and Traditional Medicine, National Institute for
Pharmaceutical Research and Development (NIPRD), Abuja.
The specimen was deposited in the NIPRD Herbarium with
voucher specimen number: NIPRD. H. 7072.
Preparation of the Plant Extract
The stem bark of S. Kunthianum was air-dried and pulverized
in a mortar and 1.6 kg (1600 g) of the pulverized sample was
macerated successively in 5 litres of 80 % v/v methanol under
a temperature of 40 on a shaker (GFL D 3006 mgH,
Germany) for agitation to ensure maximum extraction.
Double maceration was done over a period of 24 hours each.
The extract was then filtered using Whatman No 1 filter paper
and the filtrate was concentrated using rotary evaporator
(KNF RC 900 Neuberger, USA). The concentrate was then
placed over a water bath to ensure proper dryness of the
extract. The percentage yield of the extract was calculated as
follows:
Neuropathic pain: is on the other hand caused by
dysfunction or damage in the nervous system [12] and is an
inappropriate response wherein damaged nerves cause signals
to travel in abnormal pathways [13, 14].
The type of pain experienced by a patient is directly related to
the type of wound although a patient’s perception of pain is
physiologically decreased by a process of modulation (i.e.
The body’s method of decreasing pain intensity) by inhibiting
the ascending transmission of the pain impulse from the
primary afferent neuron to the second order neuron in the
spinal cord [10, 15]. It is, however, undeniable that unresolved
pain negatively impacts both wound healing and patient’s
quality of life [12].
Pain is frequently experienced and is multi-dimensional;
involving both physiological and psychological components
[16]
. The physical components include the underlying cause of
the pain and pain from clinical interventions. Pain,
undoubtedly, increases the amount of stress and anxiety that is
perceived by the patient and unaddressed pain can sensitize
all parts of the nervous system [17].
Analgesics are agents used to produce diminished sensation to
pain without loss of consciousness [18]. Many analgesics
already in use have some limitations. Hence, the need for
continuous search for new agents that will be efficacious,
safe, cheap and readily available.
Ethomedicinal report on Stereospermum kunthianum
suggested a possible usefulness of its stem bark in the
% yield = (W1 X 100)/W2
Where: W1 = Weight of dry extract; W2 = Weight of dry
plant
The extract was then stored in the refrigerator (4 oC) for the
studies.
Phytochemical Analyses
The extract was screened for the presence or absence of
various phytochemical constituents using the standard method
[21]
.
Chemical and Drugs
Analytical grade chemicals and a standard drug were used for
the studies and these included Methanol (Fluka Chemie,
Switzerland), Glacial acetic acid (Searle, Essex, England),
Formaldehyde 40 % w/v (M & B, England), Acetyl salicylic
acid (Aspar Pharmaceuticals).
~ 41 ~
Journal of Medicinal Plants Studies
http://www.plantsjournal.com
percent inhibition of inflammation in relation to the control
group. The percentage inhibition of inflammation was
calculated by the formula used by Akah and Nwambie [23] as
follows:
Animals
Wistar rats (125.0 – 256.0 g) of both sexes and Swiss albino
mice (15.0 – 30.0 g) of both sexes were used for the studies.
They were obtained from the Animal Facility Centre,
Department of Pharmacology and Toxicology, National
Institute for Pharmaceutical Research and Development
(NIPRD), Abuja, Nigeria. The experimental animals were
separated for at least two weeks in the experimental room for
acclimatization. The animals were maintained under normal
environmental temperature, approximately normal 12 h day
and night illumination cycle. They were allowed free access
to standard feed and water except when starvation was
required in the study.
Percentage inhibition= [(C-T)/C) × 100]
Where: C= Paw thickness of control rats; T= Paw thickness of
test rats
Formalin-induced oedema in rat hind paw
The study was carried out according to the modified method
adopted by Shivaji et al. [24]. Rats were grouped into five
(n=5). Each rat in group one was given distilled water (10
ml/kg p.o.) to serve as negative control. Three doses of the
extract (100, 200 and 400 mg/kg p.o.) were administered to
the second, third and fourth groups respectively. Rats in group
five received acetyl salicylic acid (ASA; 100 mg/kg p.o) to
serve as the reference standard.
One-hour post treatment, 0.1 ml of 2 % formalin was injected
into the sub-plantar area of the right hind paw of each rat.
Treatment with all the drugs was continued for seven (7)
consecutive days and treatment was once on each of these
days. The paw thickness of each of the rats was measured
using a Vernier caliper (Aerospace, China). On the first day,
zero readings were taken before the injection of 2 % formalin
and then, at 30 min, 1 h, 2 h, 3 h and 4 h post treatment.
Readings were also taken once from days 2 – 7.
The thickness of the paw at every interval was calculated in
relation to the mean paw thickness before the injection of the
2 % formalin. Activity for the treated groups were expressed
as percent inhibition of inflammation in relation to the control
group. The percentage inhibition of inflammation was
calculated using the formula described by Shivaji et al. [24] as
follows:
Acute Toxicity Studies
The modified method of Lorke [22] was adopted for the
estimation of the dose of the extract that will cause lethality of
50 % of the animal population (LD50) to which it would be
administered to. The study was carried out using oral and
intraperitoneal routes in Wistar rats and intraperitoneal route
in Swiss albino mice.
The method involves administration of the extract in a
biphasic manner. In the first phase, widely differing doses of
the extract (10, 100 and 1000 mg/kg) were administered
intraperitoneally in the rats and mice to determine the range
within which toxicity would occur. The same doses of the
extract (10, 100 and 1000 mg/kg) were also administered to
rats orally in the first phase. The second phase was dependent
on the observations made in the first phase and involved
administration of higher doses of the extract (2000, 3000 and
5000 mg/kg) intraperitoneally to new set of experimental rats
and mice. The same doses of the extract (2000, 3000 and
5000 mg/kg) were also administered orally to new set of rats
in the second phase.
The treated animals were observed for 72 h for behavioural
and\or toxic effects such as nervousness, ataxia, excitement,
alertness, dullness and death.
Percentage inhibition = [(C-T)/C) × 100]
Where: C = Paw thickness of control rats; T= Paw thickness
of test rats
Anti-Inflammatory Studies
Stereospermum kunthianum stem bark extract was evaluated
for anti-inflammatory activity using acute and chronic antiinflammatory models as follows:
Anti-Nociceptive Studies
These studies involved evaluation of the extract for antinociceptive activities and determination of the possible site(s)
of anti-nociception if there is anti-nociception.
Egg albumin - induced paw oedema in rats
The study was done according to the modified method of
Akah and Nwambie [23]. The rats to be used for the
investigation were deprived of water during the experiment to
ensure uniform hydration and minimize variability in
oedematous response. The rats were then grouped into five
(n=5). The first group was given distilled water (10 ml/kg i.p.)
to serve as negative control. Three doses of the extract (100,
200 and 400 mg/kg i.p.) were administered to the second,
third and fourth groups respectively while acetyl salicylic acid
(ASA, 100 mg/kg i.p.) was given to the fifth group to serve as
a reference standard.
Inflammation was then induced 30 min post treatment by
injecting 0.1 ml of fresh egg albumin into the sub-plantar
surface of the right hind paw of each of the rats. The paw
thickness of each of the rats was measured using a Vernier
caliper (Aerospace, China). Zero readings were taken before
the injection of egg albumin (0 min) and at 20 min intervals
after the injection of egg albumin over a 2 h (120 min) period.
The thickness of the paw at every interval was calculated in
relation to the mean paw thickness before the injection of the
egg albumin. Activity for the treated groups was expressed as
Acetic Acid-induced Writhing Test in Mice
This involved a test on chemical pain and the method used by
Chidume et al. [25] was adopted. Swiss albino mice of either
sex were used for the investigation. They were grouped into
five (n=5). Distilled water (10 ml/kg i.p) was administered to
the first group. The second, third and fourth groups received
graded doses of the extract (100, 200, 400 mg/kg i.p.)
respectively. Acetyl salicylic acid (ASA; 100 mg/kg i.p) was
administered to the mice in group five to serve as the
reference standard.
At intervals of 30, 60, 90 and 120 min post administration,
0.75 % glacial acetic acid was administered intra-peritoneally
to each mouse at the dose of 10 ml/kg. Five minutes after
acetic acid injection, the number of writhes made by each
mouse within 10 min was counted using a counter.
The percent writhes for the treated group was calculated in
relation to the control group. The activity was expressed as
percent inhibition of nociception (reduction in episodes of
writhing between the negative control and the treated groups).
~ 42 ~
Journal of Medicinal Plants Studies
http://www.plantsjournal.com
1600.0 g (1.6 kg) while the weight of S. kunthianum extract
was 279.0 g giving a percentage yield of 17.44 % (w/w). The
extract was dark brown in appearance but oily and slurry in
consistency.
Formalin-induced pain test in rats
This procedure shows the possible site(s) of anti-nociception
and was done according to the method used by Jegede et al.
[26]
. Adult wistar rats of either sex were used. They were
grouped into five (of five rats each). Distilled water (10 ml/kg
i.p) was given to rats in group one to serve as negative
control. The extract (100, 200, 400 mg/kg i.p) was given to
rats in groups two, three and four respectively. Acetyl
salicylic acid (100 mg/kg i.p) was administered to the rats in
group five to serve as reference standard.
Thirty (30) min post treatment, 50 µl (0.05 ml) of 2.5 %
formalin was injected under the plantar surface of the left hind
paw of each rat. The rats were then placed under observation.
Phytochemical Analyses
The phytochemical analyses carried out on the crude stem
bark extract showed the presence of saponins, terpenes,
tannins and steroids
Acute Toxicity Studies
No overt toxicity signs or death was observed in rats 72 h post
oral treatment with S. kunthianum extract (10 – 5,000 mg/kg).
The estimated oral median lethal dose (LD50) of the extract in
rats was therefore ≥ 5,000 mg/kg.
No death was observed in rats and mice 72 h post
intraperitoneal treatment with S. kunthianum extract (10 –
5,000 mg/kg). No overt toxicity sign was observed in rats
while mice were calm within the first 20 min. post
administration with the extract (3,000 – 5,000 mg/kg i.p). The
estimated intraperitoneal median lethal dose (LD50) of the
extract in rats and mice was therefore ≥ 5,000 mg/kg.
The severity of pain was recorded as scores
(0) = rat walked or stood firmly on the injected paw
(1) = rat partially elevated or favoured the paw
(2) = rat elevated the paw from the floor
(3) = rat licked, bit or shook the paw.
The cut off points for the observations was every 2min for the
first 10 min (early phase) and at every 5min for the period
between the 10th and 60th min (late phase).
Anti-inflammatory Studies
Egg albumin-induced paw oedema in rats
The stem bark extract of S. kunthianum (100, 200, 400 mg/kg
i. p) reduced rat paw thickness over a period of 120 min (2 h).
The reduction was significant (p < 0.05) up to 60 min. The
effect was not dose-dependent and was comparable to ASA
(100 mg/kg i.p; Figure 1). The percentage inhibition of
inflammation for S. kunthianum extract (100, 200, 400 mg/kg
i.p) was 26.2 %, 23.8 %, 33.3 % respectively. The percent
inhibition for the extract was comparable to that of acetyl
salicylic acid (ASA, 100 mg/kg i.p) with percent inhibition of
24.6 %.
Data Analyses
The results of the studies were expressed as mean ± SEM.
The differences among the treatment groups were analyzed
using Analysis of Variance (ANOVA) in the SPSS version 16
software. Tukey Post hoc Test was used to determine the
differences between treatment groups. P-values < 0.05 were
taken to be statistically significant. Results were presented as
a table and diverse charts as appropriate.
Results
Plant Extract
The weight of the pulverized S. kunthianum stem bark was
Fig 1: Effect of aqueous-methanol extract of S. kunthianum stem bark (S.K) on fresh egg albumin-induced paw oedema in rats
The paw thickness reduction by the extract (100 – 400 mg/kg)
was higher than that of ASA (100 mg/kg p.o) which had a
non-significant reduction of the rat paw thickness up to Day 4
(Figure 2). The general percentage inhibition of inflammation
for S. kunthianum extract (100, 200, 400 mg/kg i.p) was 17.7
%, 19.9 %, 21.8 % respectively.
Formalin-induced Oedema in rat hind paw
The extract of S. kunthianum (100 mg/kg p.o) reduced rat paw
thickness up to Day 6. The reduction was significantly
(p<0.05) different from the negative control up to Day 3. On
the other hand, S. kunthianum extract (200 – 400 mg/kg p.o)
caused a non-significant reduction of the rat paw thickness up
to Day 4.
~ 43 ~
Journal of Medicinal Plants Studies
http://www.plantsjournal.com
Fig 2: Effect of aqueous-methanol extract of S. kunthianum stem bark (S.K) on formalin-induced paw oedema in rats
However, S. kunthianum (200 – 400 mg/kg i.p) significantly
(p<0.05) reduced the number of writhes more than ASA (100
mg/kg i.p; Figure 3). The percent inhibition of nociception for
S. kunthianum (100, 200 and 400 mg/kg i.p) was 58.8 %, 80.7
% and 97.4 % respectively. The extract doses of 200 and 400
mg/kg showed higher percent inhibition of nociception than
acetyl salicylic acid with percent inhibition of 67.9 %.
Anti-Nociceptive Studies
Acetic Acid-induced Writhing Test in Mice
The stem bark extract of S. kunthianum (100 – 400 mg/kg i.p)
significantly (p<0.05) reduced the number of acetic acidinduced writhes in mice over the 120 min test period. The
reduction effect was dose-dependent. ASA (100 mg/kg i.p)
also caused a significant (p < 0.05) reduction of the writhes.
Fig 3: Effect of aqueous-methanol extract of S. kunthianum stem bark (S.K) on acetic acid-induced writhes in mice
extract of S. kunthianum (100, 200 and 400 mg/kg i.p) caused
a significant (p < 0.05) but non dose-dependent reduction of
formalin-induced pain at the late phase (15 – 60 min) with
mean pain scores of 12.8,15.0 and 13.6 giving percent pain
inhibition of 47.97 %, 39.02 % and 44.72 % for the respective
doses of the extract. The frequency by which the aqueousmethanol S. kunthianum (100 – 400 mg/kg i.p)-treated rats
licked, bit or shook the paw was markedly reduced between
15 – 60 minutes. This result was comparable to that of ASA
(100 mg/kg i.p) with mean pain score of 43.09 which is
equivalent to percent pain inhibition of 43.09 % at the late
phase (15 – 60 min; Table 1).
Formalin-induced Pain Test in Rats
In the early phase (0 – 10 min), the rats in the negative control
group showed mean pain score of 11.6 (equivalent to 100.0%
pain inhibition) while the aqueous-methanol extract of S.
kunthianum (100, 200 and 400 mg/kg i.p) had mean pain
scores of 11.4, 10.6 and 11.8 which are equivalent to 1.72 %,
8.60 % and -1.72 % percent pain inhibition respectively. The
rats treated with ASA (100 mg/kg i.p) showed mean pain
score of 12.6 (equivalent to -8.62 % pain inhibition) in the
early phase. In the late phase (15 – 60 min), however, the
negative control rats had mean pain score of 24.6 (equivalent
to 100.0% pain inhibition). The aqueous-methanol stem bark
~ 44 ~
Journal of Medicinal Plants Studies
http://www.plantsjournal.com
Table 1: Effect of aqueous-methanol extract of S. kunthianum stem bark (100, 200, 400 mg/kg p.o) on formalin-induced pain in rats
Treatment
Score of pain
11.6 ± 0.9
Early Phase
% Pain Inhibition
0.00
Score of pain
24.6 ± 1.2
Late Phase
% Pain Inhibition
0.00
Negative Control
S. kunthianum
100 mg/kg i.p.
11.4 ± 1.2
1.72
12.8 ± 2.2*
47.97
200 mg/kg i.p
10.6 ± 1.0
8.60
15.0 ± 0.9*
39.02
400 mg/kg i.p
11.8 ± 1.3
-1.72
13.6 ± 2.6*
44.72
ASA
100 mg/kg i.p
12.6 ± 1.0
-8.62
14.0 ± 1.0*
43.09
Values are expressed as mean ± SEM (n = 5); *P < 0.05, significantly different from the control; One-way ANOVA; Tukey post hoc.
highest effect at the highest dose. The dose to be used
clinically would therefore be dependent on the degree of
inflammation. It implies that doses can be increased as the
degree of inflammation increases.
The results for the formalin-induced oedema in rat hind paw
corroborated those of egg albumin-induced oedema. It
showed percentage inhibition of inflammation by S.
kunthianum extract (100, 200, 400 mg/kg p.o) to be 17.7 %,
19.9 % and 21.8 %. This also suggests that increasing doses
of the S. kunthianum extract might also increase the inhibitory
effect on inflammation. The study also revealed that S.
kunthianum (100 mg/kg p.o) reduced oedema up to Day 6.
This reduction was significant (p < 0.05) up to Day 3.
Furthermore, S. kunthianum (200 and 400 mg/kg p.o) caused
a non-significant reduction of rat paw oedema up to Day 4.
This suggests that S. kunthianum stem bark extract has the
potential to be developed as an anti-inflammatory agent for
both acute and sub-acute inflammation. Therapeutic
advantage can be taken of this property in the management of
chronic wounds. This is in consideration that chronic wounds
are characterized by a chronic inflammatory response which
impedes healing [31]. This anti-inflammatory effect may be
attributable to the presence of saponins in the stem bark
extract [30].
The study also revealed that S. kunthianum stem bark extract
(100 – 400 mg/kg i.p) significantly (P<0.05) and dosedependently reduced the number of acetic acid-induced
abdominal constrictions (writhes) in mice. This probably
suggests an anti-nociceptive property. This effect progressed
over the 120 min. (2 h) observation period suggesting a
possible prolongation of anti-nociception effect. The S.
kunthianum stem bark extract (200 – 400 mg/kg i.p)
significantly (P <0.05) reduced the number of writhes than
acetyl salicylic acid (ASA; 100 mg/kg i.p). The percent
inhibition of nociception for S. kunthianum stem bark extract
(100, 200, and 400 mg/kg i.p) was 58.8 %, 80.7 % and 97.4 %
respectively. The extract dose rates of 200 and 400 mg/kg
showed higher percent inhibition of nociception than acetyl
salicylic acid (ASA; 100 mg/kg i.p) which had percent
inhibition of 67.9 %. However, the stem bark extract at the
dose of 100 mg/kg i.p showed lower percent inhibition of
nociception than acetyl salicylic acid. This is an indication
that S. kunthianum stem bark extract has the potential of being
developed into analgesic with comparable effects as those of
acetyl salicylic acid.
The use of abdominal constriction (writhing) model for
detection of anti-nociceptive activity has been reported to be
more sensitive, when compared with other models such as tail
flick model [32]. The writhing response is thought to partly
involve local peritoneal receptors [33, 34, 35].
In the present investigation, formalin test was adopted to
elucidate the possible site(s) (central, peripheral, or both) of
anti-nociceptive activity observed in the extract. The results
revealed that S. kunthianum extract (100, 200 and 400 mg/kg
Discussion
Acute toxicity study was used to establish the median lethal
dose (LD50) of stem bark extract of S. kunthianum in mice and
rats treated orally and intraperitoneally. The evaluation was
useful in the determination of the working doses for the study
and for the classification of the plant extract in terms of
safety. According to Lorke [22], different substances have
different toxicity levels, hence, the classification of
substances into very toxic, toxic, less toxic or only slightly
toxic. This indicates that evaluation of safety profile of a drug
is paramount in the development of drugs and in their
subsequent clinical uses.
The present study showed that the stem bark extract of S.
kunthianum has estimated oral and intraperitoneal LD50 ≥
5,000 mg/kg in rats and intraperitoneal LD50 in mice. The
LD50 ≥ 5,000 mg/kg estimated for rats and mice in this study
indicates relative safety since Lorke [22] considered LD50
values greater than 1g (1000 mg/kg) for a test substance or
chemical as only slightly toxic (relatively safe).
The oral acute toxicity value ≥ of 5,000 mg/kg obtained in
this study for stem bark extract of S. kunthianum corroborated
the oral LD50 value of ≥ 8,000 mg/kg obtained by Ching et al.
[27]
. These results suggest that the stem bark extract of S.
kunthianum is relatively safe.
It should, however, be noted that, although acute toxicity
study (LD50) is useful, such acute toxicity data are of limited
clinical application since cumulative toxic effects do occur
even at very low doses. Hence, sub-acute and chronic toxicity
studies are almost always invaluable in evaluating the safety
profile of phytomedicines [28]. This is probably the basis for
the suggestion that sub-chronic toxicity data be used to
predict the hazard of long term, low-dose exposure to a
particular compound [29].
In the present study, egg albumin-induced oedema study
revealed that the percent inhibition was not dose-dependent
and was comparable to that of acetyl salicylic acid (ASA, 100
mg/kg i.p) with percent inhibition of 24.6 %. This could mean
that the precursors or mediators of the inflammatory process
were only minimally attenuated at these tested doses.
However, the highest percentage inhibition effect (33.3 %)
recorded at the highest dose (400 mg/kg) is indicative that the
anti-inflammatory activity of the S. kunthianum stem bark
extract may increase as its doses increase. Although the
mechanism of action for inflammatory inhibition by S.
kunthianum stem bark extract was not elucidated in the
present study, the presence of saponins may have contributed
to the anti-inflammatory effect. Navarro et al. [30] reported that
saponins have anti-inflammatory activity which can reduce
oedema and skin inflammation.
The minimal percent inhibition of inflammation (26.2 %, 23.8
% and 33.3%) exhibited by the extract (100, 200, 400 mg/kg
respectively) might just have been adequate enough to prevent
aberrant inflammatory response. The stem bark extract
exhibited inhibitory effect at all the tested doses with the
~ 45 ~
Journal of Medicinal Plants Studies
http://www.plantsjournal.com
salicylic acid (aspirin) which has analgesic and antiinflammatory properties.
In conclusion, the results corroborate the ethnomedicinal use
of S. kunthianum stem bark extract for the treatment of
inflammatory and pain-related health conditions. S.
kunthianum stem bark extract therefore has the potential to be
developed as anti-inflammatory and analgesic agent.
i.p) significantly (p < 0.05) reduced formalin-induced pain in
the late phase (15 – 60 min) of the experiment. The frequency
by which S. kunthianum extract (100, 200 and 400 mg/kg i.p)
– treated rats licked, bit or shook the paw was markedly
reduced between 15 – 60 minutes and their scores for pain
were also reduced at the late phase. However, the reduction
was not dose-dependent with percent pain inhibition of 47.97
%, 39.02 % and 44.72 % for the respective doses of the
extract. The result was comparable to that of ASA (100 mg/kg
i.p) with percent inhibition of 43.09 % at the late phase (15 –
60 min). On the other hand, S. kunthianum extract (100, 200
and 400 mg/kg i.p) produced percent pain inhibition of 1.72
%, 8.60 % and – 1.72 % respectively in the early phase (0 –
10). These effects were not different from that of the negative
control group with percent inhibition of 0.00 %.
Dubuisson and Dennis [36] and Tjolsen et al. [37] reported that
in formalin test, nociception occurs in two phases. The first
phase starts immediately after formalin injection and
continues for 5 min, after which nociception appears to
diminish. The second phase is marked by a return to high
levels of nociception beginning 15 – 20 min. after formalin
injection and continuing for 60 min. The first phase is
probably a direct result of stimulation of nociceptors in the
paw, while the second phase may reflect the inflammation
process, and at least to some degree, the sensitization of
central nociceptive neurons [38, 39]. This method is very useful
for elucidating the mechanism of pain and analgesia [37].
Drugs such as narcotics which act mainly centrally, inhibit
both phases of formalin-induced pain while drugs, such as
aspirin, hydrocortisone and dexamethasone which are
primarily peripherally acting only inhibit the late phase [40, 41,
42]
. The lower percent pain inhibition of 17.2 %, 8.60 % and 1.72 % recorded at the early phase (0 -10 min) and the higher
percent pain inhibition of 47.97 %, 39.02 % and 44.72 %
recorded at the late phase (15 - 60 min) show action of the
extract preferentially on the late phase and suggests that the
peripheral mechanism may be involved.
The higher pain inhibition percentage in the second phase of
formalin test indicates peripheral anti-inflammatory process
and suggests peripheral mechanism of pain relief. The earlier
report on the anti-inflammatory effect of the extract on fresh
egg albumin-induced oedema and formalin-induced oedema
corroborate this. It can therefore be deducted that the
peripheral mechanism may be the major mechanism involved
in the anti-nociceptive effect of S. kunthianum stem bark
extract. This could therefore mean that the extract may be of
the antipyretic analgesic type rather than the opioid analgesic.
Subsequent study will involve the interaction of the antinociceptive action of the extract with opioid antagonists such
as naloxone, to see if the effect could be reversed as is typical
of opioid analgesics.
It is important to note that some drugs such as phenacetin,
acetaminophen (paracetamol) are known to be clinically
effective analgesics, even antipyretics but lack significant
anti-inflammatory properties while other drugs such as
phenylbutazone are potent anti-inflammatory agents but lack
or have only weak analgesic properties. Others have both
analgesic and anti-inflammatory properties e.g. acetyl
salicylic acid (aspirin). The present investigation has shown
that S. kunthianumstem bark extract inhibited egg albumininduced oedema (inflammation), formalin-induced oedema
(inflammation), acetic acid-induced writhes (chemical pain
test) and formalin-induced pain showing. Although the
antipyretic activity of the extract is yet to be evaluated, it is
possible that the extract belongs to the same group as acetyl
Acknowledgement
The technical assistance of staff of National Institute for
Pharmaceutical Research and Development (NIPRD), Idu,
Abuja, Nigeria is appreciated by the authors.
Authors’ Contributions
Prof. Paul Abdu and Dr Shehu NaAllah Alhaji Saidu played
supervisory and quality assurance roles in the study. Prof.
Florence Chimezie Nwinyi was the Principal Investigator and
she worked in collaboration with Dr Joseph Omamegbe. Mr
Adamu Mohammed provided the technical assistance.
Funding
The study was self-sponsored
Availability of Data and Materials
All the relevant data and materials have been presented in the
manuscript
Ethical Approval
Approval of research protocol was obtained from University
of Abuja Ethics Committee on Animal Use (UAECAU) with
reference number: UAECAU/2018/006. The research was
conducted according to the internationally accepted principles
for laboratory animal use and care of the NIH publication no.
85-23.
Consent for Publication
Not applicable
Conflict of Interests
No conflict of interest was declared by the authors.
References
1. Durum SK, Oppenheium JJ. Macrophage derived
mediator: interleukin 1, tumor necrosis factor, interleukin
6, interferon and related cytokines. In: Paul, W.E.
Fundamental Immunology (2ndEd), Raven Press Ltd,
New York 1989.
2. Insel PA. Analgesic, antipyretics and Anti-inflammatory
Agents: Drugs employed in the treatment of rheumatoid
arthritis and gout. In: Goodman and Gilman
Pharmacological Basis for Therapeutics. 8th Ed.,
Pergamon Press, New York 1990, 638-681.
3. Ward PA. Mechanism of tissue injury: inflammation. In:
Bellanti, J.A Immunology II. (Ed).W.B. Saunders
Company, USA 1978, 283-291.
4. Ulirsch CR, Gomez MD. Effusions In: Local Invasion
and Spread of Cancer 1989, 195-213. DOI: 10.1007/978 94 - 009-1093-5-18.
5. Masud HK, Raul EE, Rick AN, Lawrence JS, Sharonne
NH, Rowlens MM et al. Pericardial Disease: Diagnosis
and
Management.
Mayo
Clinic
Proceedings
2010;85(6):572-593.
6. Henson MP. Mechanism of tissue injury by immunologic
reactions. In: Bellanti JA. Immunology II (ED), WB
Saunders Company, USA 1978, 292-354.
~ 46 ~
Journal of Medicinal Plants Studies
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
http://www.plantsjournal.com
26. Jegede IA, Nwinyi FC, Ibrahim J, Ugbabe G, Dzarma S,
Kunle OF. Investigation of phytochemical, antiinflammatory and antinociceptive properties of Ipomoea
asarifolia leaves. Journal of Medicinal Plants Research
2009;3(3):160-165.
27. Ching FP, Omogbai EKL, Okpo SO, Ozolua RI.
Antiinflammatory activity of aqueous Stereospermum
kunthianum (Cham, Sandrine Petit) stem bark in rats.
Indian
Journal
of
Pharmaceutical
Sciences
2009;71(1):106-110.
28. Aniagu SO, Nwinyi FC, Akumka DD, Ajoku GA,
Dzarma S, Izebe KS et al. Toxicity studies in rats fed
nature cure bitters. African Journal of Biotechnology
2005;4(1):72-78.
29. McNamara BP. Concepts in Health Evaluation of
Commercial and Industrial Chemicals. In: Mehlman MA,
Shapiro RE, Blumental. New concepts in safety
evaluation. (Ed), Hemisphere, Washington DC 1976.
30. Navarro P, Giner RM, Recio MC, Manez S. CerdaNicolas M, Rios JL. In vivo anti-inflammatory activity of
saponins from Bupleurum rotundifolium. Life Science
2001;68:1199-1206.
31. Supernaw R. Drug Management of Pain: Pain
Management: A Practical Guide for Clinicians. 6th
Edition, CRS Press, Florida 2002, 435-439.
32. Bentley GA, Newton SH, Starr JB. Evidence for an
action of morphine and the enkephalins on sensory nerve
ending in the mouse peritoneum. British Journal of
Pharmacology 1981;73:325-332.
33. Bentley GA, Newton SH, Starr JB. Studies on the antinociceptive action of alpha antagonist drugs and their
interaction with opioid mechanisms. British Journal of
Pharmacology 1983;79:125-134.
34. Mat Jais AM, Dambisya YM, Lee TJ. Anti-nociceptive
activity of Channa striatus (haruan) extracts in mice.
Journal of Ethnopharmacology 1997;57:125-130.
35. Atta AH, Alkofahi A. Anti-nociceptive and antiinflammatory effects of some Jordian Medicinal extracts.
Journal of Ethnopharmacology 1998;60:117-124.
36. Dubuisson D, Dennis SG. The formalin test: A
quantitative study of the analgesic effect of morphine,
mepetidin and brain stem stimulation in rats and cats.
Pain 1977;4:161-174.
37. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K.
The formalin test: An evaluation of the method. Pain
1992;51:5-17.
38. Coderre TJ, Vacarino AL, Melzack R. Central nervous
system plasticity in the tonic pain response to
subcutaneous formalin injection. Brain Research
1990;535:155-158.
39. Coderre TJ, Melzack R. The contribution of excitatory
amino acids to central sensitization and persistent
nociception after formali-induced tissue injury. Journal of
Neuroscience 1992;12:3665-3670.
40. Chen YF, Tsai HY, Wu TS. Anti-inflammatory and
analgesic activity from roots of Angelica pubescens,
Planta Medica 1995;61:2-8.
41. Elisabetsky E, Amador TA, Albuquerque RR, Nunes DS,
Carvalho ACT. Analgesic activity of Psychotria colorata
(Wild, ex R and S.) Muell. Arg. Alkaloids. Journal of
Ethnopharmacology 1995;48:77-83.
42. Santos ARS, Filho VC, Niero R, Yunes RA, Calixto JB.
Analysis of the mechanisms underlying the
antinociceptive effect of the extract of plants from the
genus
Phyllantus.
General
Pharmacology
1995;26(7):199-1506.
Fauci AS. Clinical aspects of immunosuppression: use of
cytotoxic agents and corticosteroids. In: Bellanti JA.
Immunology II (Ed.), WB Saunders Company, USA
1978, 740-757.
Waksal S. Immunomodulation: Immunopotentiation,
tolerance and immunosuppression. In: Bellanti, J.A.
Immunology II (Ed), W.B. Saunders Company, USA
1978, 243-265.
IASP. Pain Terms. A list with definitions and Notes on
Usage Recommended by the IASP subcommittee on
Taxonomy Pain 1979;6(3):249-252 [PubMed].
Giordano J. The Neurobiology of pain: Pain
management: A practical Guide for Clinicians. 6th
Edition. CRS Press; Florida 2002, 1089-1100.
Choiniere M. Burn Pain: A Unique Challenge. Pain
Clinical Updates 2001;9:1-4.
MEP. Minimizing Pain at Wound Dressing-related
Procedures. A Concensus Document, World Union of
Wound
Healing
Societies
Initiative,
Wounds
International Ltd., London 2004.
Bowell M, Rosenberg SK, Chelimsky TC. Neuropathic
Pain: Mechanisms and Management: Pain Management:
A Practical Guide for Clinicians. 6th Edition. CRS Press;
Florida 2002, 181-194.
Sussman C, Bates-Johnson B. Wound Care: A
Collaborative Practice Manual for Health Professionals.
3rd Edition. Lippincott, Williams and Wilkins; Baltimore
2007;46(250):280-287.
Cox RC, Min D. Essman J Variables in the Sensation and
Perception of Pain: Pain Management: A practical Guide
for Clinicians. 6th Edition: CRS Press; Florida 2002, 817824.
Price PE, Fagervik-morton H, Mudge EJ. Dressingrelated Pain in Patients with Chronic Wounds: An
International Patient Perspective, International Wound
Journal 2008;5(2):159-171.
Wulf H, Baron R. The Theory of Pain. EWMA Position
Document. Medical Edition Partnership Ltd; London
2004, 8-11.
Aliu
YO.
Neuropharmacology:
In
Veterinary
Pharmacology (1st edition). Tamaza Publishing Company
Ltd., Zaria, Nigeria 2007, 111-134.
Burkill HM. The Useful Plants of West Tropical Africa,
2nd Edition, Vol 1, Families A-D. Royal Botanic Gardens,
Kew, Richmond, United Kingdom 1985, 960.
Irvine FR. Woody Plants of Ghana: leaf analysis with
special reference to their uses. Oxford University Press,
London 1961, 741, 1xxxii.
Trease GE, Evans WC. Pharmacolognosy, 11th Edition.,
Macmillan Publishers, London, UK 1989.
Lorke D. A new approach to acute toxicity testing.
Archives of Toxicology 1983;54:275-287.
Akah PA, Nwambie AI. Evaluation of Nigeria
Traditional Medicine. Plants useful for rheumatic
disorders. Journal of Ethno pharmacology 1994;42:179182.
Shivaji B, Tapas KS, Suvra M, Prabhash CD, Sridhar S.
Assessment of the anti-inflammatory effects of Swertia
chirata in acute and chronic experimental models in male
albino rats. Indian Journal of Pharmacology 2000;32:2124.
Chidume FC, Kwanashie HO, Adekeye JO, Wambebe C,
Gamaniel KS. Antinociceptive and smooth muscle
contracting activities of the methanolic extract of Cassia
tora leaf. Journal of Ethnopharmacology 2002;81:205209.
~ 47 ~